cytidine triphosphate has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Chen, M; Chen, X; Fu, F; Guo, W; Jiang, M; Jin, X; Li, Y; Lin, Y; Song, C; Wang, C; Xiao, H; Zhang, J; Zhang, W | 1 |
1 other study(ies) available for cytidine triphosphate and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytidine Triphosphate; Gene Expression Regulation, Neoplastic; Humans; Mice; Nucleotides; Transcriptional Activation; Triple Negative Breast Neoplasms; Y-Box-Binding Protein 1 | 2022 |